ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Juvenile Arthritis"

  • Abstract Number: 157 • 2020 Pediatric Rheumatology Symposium

    Chondrocytes Influence Fibroblast-like Synoviocytes from Patients with Juvenile Idiopathic Arthritis, Through the Abrogation of BMP Signaling, to Delay Cell Differentiation and Maturation

    Megan Simonds 1, Amanda Schlefman 2, Kathleen Sullivan 3, Carlos Rose 4 and AnneMarie Brescia5, 1Nemours Biomedical Research, Wilmington, 2Johns Hopkins Rheumatology, ST PETERSBURG, Florida, 3The Children's Hospital of Philadelphia, Philadelphia, 4Thomas Jefferson University/duPont Hospital for Children, Wilmington, 5Nemours/ Alfred I duPont Hospital for Children, Wilmington

    Background/Purpose: Juvenile Idiopathic Arthritis (JIA) progression leads to growth disturbances in affected joints. Fibroblast-like synoviocytes (FLS) play a key role in JIA pathogenesis; however, the…
  • Abstract Number: 1812 • 2019 ACR/ARP Annual Meeting

    Delineating Early Response Trajectories to Biologics in Polyarticular Course Juvenile Idiopathic Arthritis

    Lily SH Lim1, Armend Lokku 2, Sarah Ringold 3 and Eleanor M. Pullenayegum 4, 1University of Manitoba, Winnipeg, MB, Canada, 2University of Toronto, TOronto, ON, Canada, 3Seattle Children's, Seattle, 4Child Health Evaluative Sciences, The Hospital for Sick Children, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada

    Background/Purpose: Most biologic trials in juvenile idiopathic arthritis (JIA) treat all participants with the biologic under study for 12 to 16 weeks before randomizing responders…
  • Abstract Number: 1951 • 2019 ACR/ARP Annual Meeting

    Transcriptomic Responses in CD4+ T Cells During Successful Therapy for Juvenile Idiopathic Arthritis

    Tarbell Evan 1, Kaiyu Jiang 1, Tao Liu 2 and James N. Jarvis3, 1University at Buffalo Jacobs School of Medicine, Buffalo, NY, 2Roswell Park Cancer Instiyute, Buffalo, NY, 3University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY

    Background/Purpose: We have shown that therapeutic response in juvenile idiopathic arthritis (JIA) is a non-linear process invloving reorganization of gene expression networks. However, our earlier…
  • Abstract Number: 2723 • 2019 ACR/ARP Annual Meeting

    Alagille Syndrome and Chronic Arthritis: An International Case Series

    Giovanna Ferrara 1, Teresa Giani1, Scott M Lieberman 2, Sandy Hong 3, Courtney Kremer 3, Giuseppe Indolfi 1, Grant Schulert 4, Randy Cron 5, Melissa Mannion 6, Sivia Lapidus 7, Emmanuel Jacquemin 8, Isabelle Kone-Paut 9 and Rolando Cimaz 10, 1Anna Meyer Children University Hospital, Florence, Italy, 2University of Iowa, Iowa City, Iowa City, 3University of Iowa, Iowa City, Iowa City, IA, 4Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5University of Alabama at Birmingham, Birmingham, AL, 6University of Alabama at Birmingham, Alabama, 7Joseph M. Sanzari Children’s Hospital, Hackensack Meridian Health, New Jersey, 8Le Kremlin Bicetre, Paris, France, 9Rhumatologie pédiatrique et CEREMAIA,, Université Paris-Sud Saclay, Paris, France, 10Meyer Children's Hospital in Florence, Florence, Italy

    Background/Purpose: Alagille syndrome is a complex multisystem disease characterized by chronic cholestasis due to a paucity of intrahepatic bile ducts, congenital heart disease and ocular…
  • Abstract Number: PP05 • 2018 ACR/ARHP Annual Meeting

    Integrative Approach to Treatment of an Adult with Juvenile Rheumatoid Arthritis

    Shannan O'Hara-Levi, Patient, Staten Island, NY

    Background/Diagnosis: I was diagnosed in 1987 at age 3 with Polyarticular Juvenile Rheumatoid Arthritis which effected every joint in my body. At time of diagnosis…
  • Abstract Number: 1427 • 2018 ACR/ARHP Annual Meeting

    A New Model of Care for Pediatric Rheumatology in Ontario: Preliminary Results from Pilot Telemedicine Clinics Utilizing Advanced Clinician Practitioners in Arthritis Care

    Roberta Berard1, Susan MacQueen2, Michelle Diebold3, Y. Ingrid Goh4, Anne MacLeod5, Kristi Whitney-Mahoney6, Christine O'Brien6, Brian M. Feldman7 and Deborah M. Levy8, 1Pediatrics, Children's Hospital, London Health Sciences Centre, London, ON, Canada, 2The Arthritis Society, Kitchener, ON, Canada, 3Department of Rheumatology, Children's Hospital, London Health Sciences Centre, London, ON, Canada, 4Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada, 5The Arthritis Society, Thunder Bay, ON, Canada, 6The Hospital for Sick Children, Toronto, ON, Canada, 7Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 8Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

    AbstractBackground/Purpose: Twenty-five pediatric rheumatologists (PR) service a population of 14 million Ontarians. To facilitate care to patients living in distance communities we proposed a new…
  • Abstract Number: 2401 • 2018 ACR/ARHP Annual Meeting

    The Effects of a Gluten-Free Diet in Juvenile Idiopathic Arthritis – a Pilot Study

    Anjali Sura1, Stacey Fogarty-Brown2 and Meredith Riebschleger3, 1Pediatric Rheumatology, University of Michigan, Ann Arbor, MI, 2Pediatrics, University of Michigan, Ann Arbor, MI, 3Pediatric Rheumatology & Health Services Research, University of Michigan, Ann Arbor, MI

    Background/Purpose: The caregivers of children with juvenile idiopathic arthritis (JIA) frequently ask about the utility of dietary restrictions. Some patients and physicians report a good…
  • Abstract Number: 2402 • 2018 ACR/ARHP Annual Meeting

    Acoustic Emissions Generated By the Temporomandibular Joint of Patients with Juvenile Idiopathic Arthritis and Their Implication on Patient Assessment and Screening: A Pilot Study

    Daniel Whittingslow1,2, Hyeon Ki Jeong3, Talia Gergely4, Lori Ponder4, Sampath Prahalad5, Omer Inan3 and Shelly Abramowicz6, 1Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA, 3Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, 4Emory University, Atlanta, GA, 5Pediatrics, Emory University, Atlanta, GA, 6Surgery, Emory University/Children's Healthcare of Atlanta, Atlanta, GA

    Background/Purpose: The temperomandibular joint (TMJ) is one of the most commonly affected joints in juvenile idiopathic arthritis (JIA) (up to 45% of cases). There is a discrepancy between…
  • Abstract Number: 2306 • 2017 ACR/ARHP Annual Meeting

    Demographic and Clinical Characteristics of Hispanic Children with Juvenile Idiopathic Arthritis: An International, Multicenter Cross-Sectional Study

    Martha Rodriguez1, Melissa Tesher1, Deirdre De Ranieri1, Linda Wagner-Weiner2, Tamar Rubinstein3, Janet Orrock4, Christine Arango5, Angela Mosquera5, Carmen Tineo6, Romilda Salas7, Esthela Loyo8, Karen Onel9 and Maria Alkureishi10, 1Pediatric Rheumatology, The University of Chicago Medicine, Chicago, IL, 2The University of Chicago Medicine, Chicago, IL, 3Albert Einstein College of Medicine, Children's Hospital at Montefiore, New York, NY, 4Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, NY, Albania, 5Pediatric Rheumatology, Pediatric rheumatology post graduate program El Bosque University, Bogota, Colombia, 6Division of Rheumatology, Hospital Regional Universitario José Ma Cabral Baez, Santiego, Dominican Republic, 7Rheumatology, Hospital Regional Universitario José Ma Cabral Baez, Santiago, Dominican Republic, 8Departamento de Reumatologia, Hospital Regional Universitario José Ma Cabral Baez, Santiago, Dominican Republic, 9Division of Pediatric Rheumatology, University of Chicago, Chicago, IL, 10Pediatrics, The University of Chicago Medicine, Chicago, IL

    Background/Purpose: Higher disease activity has been described in Hispanic patients with Juvenile Idiopathic Arthritis (JIA) living in the United States (US) vs non-Hispanics. There is…
  • Abstract Number: 2310 • 2017 ACR/ARHP Annual Meeting

    Increased Risk of Extreme Obesity in Adults with History of Childhood Arthritis

    Sangeeta Sule1 and Kevin Fontaine2, 1Pediatrics, Johns Hopkins University, Baltimore, MD, 2Dept. of Health Behavior, Univ. of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Over one-third of U.S. adults are obese, leading to major health conditions and increased costs. Identified risk factors that contribute to obesity include lifestyle,…
  • Abstract Number: 2317 • 2017 ACR/ARHP Annual Meeting

    Knowledge Translation in Juvenile Idiopathic Arthritis in Canada: A Focus on Parents of Children with JIA

    Julia Wright1, Benjamin Rose-Davis2, Michelle Batthish3, Tania Cellucci4, Ciarán M. Duffy5, Lori Tucker6, Adam Huber7, Bianca Lang8, Deborah M. Levy9, Dax Rumsey10, Karen N Watanabe Duffy11, Janet Curran12 and Elizabeth Stringer13, 1Faculty of Medicine, Dalhousie University, Halifax, NS, Canada, 2Department of Computer Science, Health Informatics, Dalhousie University, Halifax, NS, Canada, 3Division of Pediatric Rheumatology, McMaster Children's Hospital, Hamilton, ON, Canada, 4McMaster University, hamilton, ON, Canada, 5Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 6BC Children's Hospital, Vancouver, BC, Canada, 7IWK Health Centre, Halifax, NS, Canada, 8Pediatrics, IWK Health Centre, Halifax, NS, Canada, 9Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 10Stollery Children's Hospital, Edmonton, AB, Canada, 11Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 12Department of Pediatrics, IWK Health Centre, Halifax, NS, Canada, 13Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada

    Background/Purpose: The Research in Canadian Children with Childhood Arthritis Emphasizing Outcomes (ReACCh-Out) cohort (2005-2010) has characterized outcomes for Canadian children with Juvenile Idiopathic Arthritis (JIA).…
  • Abstract Number: 2326 • 2017 ACR/ARHP Annual Meeting

    Modeling Transcriptional Rewiring in Neutrophils through the Course of Treated Juvenile Idiopathic Arthritis

    Zihua Hu1, Kaiyu Jiang2, Mark B. Frank3, Yanmin Chen2 and James Jarvis4, 1Center for Computational Research, University at Buffalo, Buffalo, NY, 2Pediatrics, University at Buffalo, Buffalo, NY, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Genetics, Genomics & Bioinformatics, University at Buffalo, Buffalo, NY

    Background/Purpose: We have previously shown that neutrophils in children with polyarticular juvenile idiopathic arthritis (JIA) display abnormal transcriptional patterns linked to fundamental metabolic derangements. These…
  • Abstract Number: 2328 • 2017 ACR/ARHP Annual Meeting

    Characterisation of Lipid Mediator Profile and Immune Cells in Synovial Fluid of Juvenile Idiopathic Arthritis

    Johannes Hendrick von Hegedus1, Q. S. R. Madari2, P.C.E. Hissink Muller3, M. Kloppenburg4, REM Toes4, Martin Giera5, TWJ Huizinga4, Rebecca ten Cate6 and A. Ioan-Facsinay4, 1Department of Rheumatology, LUMC, Leiden, Netherlands, 2LUMC, Leiden, Netherlands, 3Willem-Alexander Children's Hospital, LUMC, Leiden, Netherlands, 4Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands, 6Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is often accompanied by inflammation of the joints. The mechanisms involved in the inflammation in JIA are incompletely understood. Several…
  • Abstract Number: 2330 • 2017 ACR/ARHP Annual Meeting

    Evidence for Alternatively Activated (M2) Macrophage Activation in Patients with Enthesitis Related Arthritis Category of Juvenile Idiopathic Arthritis

    Amita Aggarwal1, Priyanka Gaur2 and Akhilesh Yadav3, 1Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 3Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Background/Purpose: Among juvenile idiopathic arthritis (JIA), enthesitis related arthritis (ERA) category includes most children with juvenile onset spondyloarthropathy (SpA). Synovial fluid from patients with SpA…
  • Abstract Number: 339 • 2017 ACR/ARHP Annual Meeting

    Patients’ Attitudes and Experiences of Transitional Care in Paediatric Rheumatology: A Systematic Review of Qualitative Studies

    Ayano Kelly1,2,3,4, Fiona Niddrie5, David Tunnicliffe4,6, Camilla Hanson4,7, Gabor Major8,9, Davinder Singh-Grewal10,11,12 and Allison Tong4, 1Rheumatology, The Canberra Hospital, Canberra, Australia, 2School of Medicine, Australian National University, Canberra, Australia, 3Canberra Rheumatology, Canberra, Australia, 4Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia, 5Rheumatology, Bone and Joint Institute,John Hunter Hospital, Newcatle, Australia, 6Sydney School of Public Health, University of Sydney, Sydney, Australia, 7Sydney School of Pubic Health, University of Sydney, Sydney, Australia, 8Medicine, University of Newcastle, Newcastle, Australia, 9Rheumatology, Bone and Joint Institute, John Hunter Hospital NSW Australia, Newcastle, Australia, 10Faculty of Medicine, University of New South Wales, Sydney, Australia, 11Department of Rheumatology, The Sydney Children's Hospital Network, Sydney, Australia, 12Sydney Medical School, University of Sydney, Sydney, Australia

    Background/Purpose: Despite the increasing number of transition programs available for rheumatology patients moving from paediatric to adult care, transition continues to pose challenges for patients…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology